摘要
目的对目前已有药物经济学文献质量评价工具的内容、特点进行比较分析,对如何选择最优的质量评价工具给出建议。方法计算机检索PubMed、EMbase、ScienceDirect、Web of Science、CNKI、WanFang Data和VIP数据库,搜集有关药物经济学质量评价工具的研究,检索时限均为建库至2017年12月。由2名研究者独立筛选文献、提取资料并从条目内容、设计方法、适用范围和各自特点等方面进行详细分析。结果共纳入信度、效度较好的原创评估量表12个,其中最早的质量评估量表设计于1987年,最新的发表于2013年,条目数量从11个到61个不等。结论药物经济学研究的质量评价迄今尚无统一方法。评价者可根据评价目的、评价类型及可操作性等,选择适宜的评价工具。
Objectives To compare and analyze existing pharmaceutical economic evaluations quality assessment instruments, and to provide suggestions on how to choose the most appropriate instrument.Methods PubMed, EMbase, ScienceDirect, Web of Science, CNKI, WanFang Data and VIP databases were electronically searched to collect studies on existing pharmaceutical economic evaluations quality assessment instruments from inception to December, 2017. Two reviewers independently screened literature, extracted data and analyzed studies in terms of items, design methods, scopes and characteristics. Results Twelve original checklists with good reliability and validity were found. The first quality assessment method was designed in 1987 and the latest one was published in 2013.The number of checklist items ranged from 11 to 61. Conclusion There is no consolidated method for assessing the quality of pharmaceutical economics evaluations. Evaluators can choose appropriate evaluation tools according to the purpose, type and operability of evaluation.
作者
张诗雨
马爱霞
李洪超
管欣
ZHANG Shiyu;MA Aixia;LI Hongchao;GUAN Xin(School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing,211198,P.R.China)
出处
《中国循证医学杂志》
CSCD
北大核心
2019年第7期844-850,共7页
Chinese Journal of Evidence-based Medicine
关键词
药物经济学
质量评价工具
信度
效度
Pharmaceutical economic
Quality assessment instrument
Reliability
Validity
